文献速递妇科生殖医学

使用卵巢静脉进行静脉引流的改良人类子宫移植:首例机器人辅助子宫获取手术成功并随访12个月的报告

Modified human uterus transplantation using ovarian veins for venous drainage: the first report of surgically successful robotic-assisted uterus procurement and follow-up for 12 months.
PubMed 文献 · Fertil Steril · 2017-01-01

本病例报告描述了首例使用机器人辅助子宫获取的人类子宫移植,受者为22岁完全苗勒管发育不全女性,供者为其母亲。手术包括机器人辅助子宫获取、原位放置固定及双侧腹下动脉和卵巢-子宫静脉与双侧髂外动静脉端侧吻合。随访12个月,受者术后40天月经初潮,已有12个月经周期,无排斥反应,供受者均无围手术期并发症。

要点

  • 首例机器人辅助子宫获取的活体供者子宫移植,受者22岁完全苗勒管发育不全。
  • 受者术后40天月经初潮,12个月内共12个月经周期,无排斥反应。
  • 供者和受者手术时间分别为6小时和8小时50分钟,无即刻围手术期并发症。

核心结论

  • 结果表明,采用低剂量免疫抑制方案的活体供者子宫移植可行,且DaVinci机器人辅助在人类子宫获取中发挥作用。

研究设计与样本

  • 病例研究,于大学医院开展。
  • 受者为22岁完全苗勒管发育不全女性,此前曾接受阴道重建手术;活体子宫供者为其母亲。

主要发现

  • 供者手术时间6小时,受者手术时间8小时50分钟。
  • 受者和供者均无即刻围手术期并发症。
  • 受者术后40天月经初潮,自手术以来已有12个月经周期。
  • 受者未发生排斥反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the 12-month results of the first human uterus transplantation case using robot-assisted uterine retrieval. This type of transplantation may become a treatment for permanent uterine factor infertility. DESIGN: Case study. SETTING: University hospital. PATIENT(S): A 22-year-old woman with complete müllerian agenesis who underwent a previous surgery for vaginal reconstruction. The live uterine donor was her mother. INTERVENTION(S): The uterus transplantation procedure consisted of robot-assisted uterine procurement, orthotopic replacement and fixation of the retrieved uterus, revascularization, and end-to-side anastomoses of bilateral hypogastric arteries and ovarian-uterine vein to the bilateral external iliac arteries and veins. MAIN OUTCOME MEASURE(S): Data from preoperative investigations, surgery, and follow-up (12 months). RESULT(S): The duration of the donor and recipient surgeries were 6 and 8 hours, 50 minutes, respectively. No immediate perioperative complications occurred in the recipient or donor. The recipient experienced menarche 40 days after transplant surgery, and she has had 12 menstrual cycles since the surgery. No rejection episodes occurred in the recipient. CONCLUSION(S): These results demonstrate the feasibility of live-donor uterine transplantation with a low-dose immunosuppressive protocol and the role of DaVinci robotic assistance during human uterine procurement. CLINICAL TRIAL REGISTRATION NUMBER: XJZT12Z06.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Wei L, Xue T, Tao KS, et al. Modified human uterus transplantation using ovarian veins for venous drainage: the first report of surgically successful robotic-assisted uterus procurement and follow-up for 12 months. Fertil Steril. 2017. PMID: 28778283. doi:10.1016/j.fertnstert.2017.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。